Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its Pharmaceuticals segment.

Cardinal Health has reported second quarter revenue for its “other” businesses, which includes at-Home Solutions, increased 13% to $1.3 billion.

Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...

Cardinal Health said its contracts with the pharmacy benefits provider of UnitedHealth Group, OptumRX, won't be renewed, and shares fell in intraday trading Monday. The health insurer noted that ...

Cardinal Health, Inc. operates as a healthcare services ... providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including ...

Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc. Earnings Conference Call. My name is George, and I'll be coordinator for today's event. Please note, this conference is ...

Cardinal expects full-year earnings to be $7.85 to $8 per share. Cardinal shares have climbed 8% since the beginning of the year, while the S&P's 500 index has climbed 27%. The stock has risen 20% in ...

In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against the other stocks. In one of his latest appearances on CNBC's Squawk on the Street, Jim Cramer ...